Choice of calcineurin inhibitor and development of new malignancies in liver transplant recipients

被引：0
|
作者：
Blum, Eric B. [1 ]
Post, Anthony B. [1 ]
机构：
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2006年 / 101卷 / 09期
关键词：
D O I：
10.14309/00000434-200609001-00319
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
319
引用
收藏
页码：S150 / S150
页数：1
相关论文
共 50 条
  • [1] Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients
    Penninga, Luit
    Wettergren, Andre
    Chan, An-Wen
    Steinbuechel, Daniel A.
    Gluud, Christian
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (03):
  • [2] Suitable Calcineurin Inhibitor Concentrations for Liver Transplant Recipients in the Chinese Population
    Chen, Y. B.
    Li, S. D.
    Ju, B. L.
    Shi, X. J.
    Lu, F.
    Hu, D. K.
    Yu, C. H.
    Dong, J. H.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (05) : 1751 - 1753
  • [3] Genotype and choice of calcineurin inhibitor influence response to antiviral therapy in liver transplant recipients treated for recurrent HCV
    Selzner, Nazia
    Girgrah, Nigel
    Al Adawi, Ismail
    Wong, Philip
    Levy, Gary
    McQuarrie, Brenda
    Cattral, Mark
    Greig, Paul
    McGilvray, Ian
    Grant, David
    Lilly, Les
    HEPATOLOGY, 2006, 44 (04) : 481A - 481A
  • [4] CALCINEURIN INHIBITOR WITHDRAWAL IN THE PRESENCE OF EVEROLIMUS IS FEASIBLE IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS
    Fischer, Lutz
    De Simone, Paolo
    Nevens, Frederik
    Metselaat, Herold J.
    Dumortier, Jerome
    Duvoux, Christophe
    Boudjema, Karim
    Le Treut, Yves Patrice
    Sterneck, Martina R.
    HEPATOLOGY, 2008, 48 (04) : 566A - 566A
  • [5] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 714 - 715
  • [6] Experience With Everolimus Following Calcineurin Inhibitor Withdrawal in Liver Transplant Recipients.
    Fischer, L.
    Fung, J.
    Metselaar, H.
    Kaiser, G.
    Schemmer, P.
    Neuhaus, P.
    Dong, G.
    Junge, G.
    Schlitt, H.
    TRANSPLANTATION, 2014, 98 : 714 - 715
  • [7] Choice of calcineurin inhibitor as well as genotype incluence response to antiviral therapy in liver transplant recipients treated for recurrent HCV.
    Lilly, Leslie B.
    Selzner, Nazia
    Wong, Philip
    Therapondos, George
    Levy, Gary A.
    Cattral, Mark S.
    Greig, Paul D.
    McGilvray, Ian
    Grant, David R.
    Girgrah, Nigel
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 240 - 240
  • [8] POSTTRANSPLANT MALIGNANCIES IN LIVER TRANSPLANT RECIPIENTS
    Moray, Gokhan
    Akdur, Aydincan
    Kirnap, Mahir
    Karakayaly, Feza Yarbug
    Yildirim, Sedat
    Haberal, Mehmet
    TRANSPLANT INTERNATIONAL, 2013, 26 : 304 - 304
  • [9] Posttransplant Malignancies in Liver Transplant Recipients
    Akdur, Aydincan
    Kirnap, Mahir
    Yildirim, Sedat
    Altundag, Ozden
    Moray, Gokhan
    Haberal, Mehmet
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 : 162 - 165
  • [10] Calcineurin-inhibitor related nephrotoxicity-reversibility in paediatric liver transplant recipients
    Aw, MM
    Samaroo, B
    Baker, AJ
    Verma, A
    Rela, M
    Heaton, ND
    Mieli-Vergani, G
    Dhawan, A
    TRANSPLANTATION, 2001, 72 (04) : 746 - 749
12345